Minimum Transendothelial Electrical Resistance Thresholds for the Study of Small and Large Molecule Drug Transport in a Human in Vitro Blood-Brain Barrier Model

被引:62
|
作者
Mantle, Jennifer L.
Min, Lie
Lee, Kelvin H. [1 ]
机构
[1] Univ Delaware, Dept Chem & Biomol Engn, 15 Innovat Way, Newark, DE 19711 USA
基金
美国国家科学基金会;
关键词
blood-brain barrier; drug transport; human induced pluripotent stem cells; IgG transport; human brain microvascular endothelial cells; Alzheimer's disease; CELLS; PERMEABILITY; OPTIMIZATION; DERIVATION; CULTURE;
D O I
10.1021/acs.molpharmaceut.6b00818
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A human cell-based in vitro model that can accurately predict drug penetration into the brain as well as metrics to assess these in vitro models are valuable for the development of new therapeutics. Here, human induced pluripotent stem cells (hPSCs) are differentiated into a polarized monolayer that express blood brain barrier (BBB)-specific proteins and have transendothelial electrical resistance (TEER) values greater than 2500 Omega.cm(2). By assessing the permeabilities of several known drugs, a benchmarking system to evaluate brain permeability of drugs was established. Furthermore, relationships between TEER and permeability to both small and large molecules were established, demonstrating that different minimum TEER thresholds must be achieved to study the brain transport of these two classes of drugs. This work demonstrates that this hPSC-derived BBB model exhibits an in vivo-like phenotype, and the benchmarks established here are useful for assessing functionality of other in vitro BBB models.
引用
收藏
页码:4191 / 4198
页数:8
相关论文
共 50 条
  • [11] Butyric acid mediated induction of enhanced transendothelial resistance in an in vitro model blood-brain barrier system
    Hurst, RD
    Clark, JB
    NEUROCHEMISTRY INTERNATIONAL, 1999, 35 (03) : 261 - 267
  • [12] Transendothelial Electrical Resistance Measurement across the Blood-Brain Barrier: A Critical Review of Methods
    Vigh, Judit P.
    Kincses, Andras
    Ozgur, Burak
    Walter, Fruzsina R.
    Santa-Maria, Ana Raquel
    Valkai, Sandor
    Vastag, Monika
    Neuhaus, Winfried
    Brodin, Birger
    Der, Andras
    Deli, Maria A.
    MICROMACHINES, 2021, 12 (06)
  • [13] Transendothelial permeability changes induced by free radicals in an in vitro model of the blood-brain barrier
    Lagrange, P
    Romero, IA
    Minn, A
    Revest, PA
    FREE RADICAL BIOLOGY AND MEDICINE, 1999, 27 (5-6) : 667 - 672
  • [14] Zinc transport across an in vitro blood-brain barrier model
    Bobilya, DJ
    Guerin, JL
    Rowe, DJ
    JOURNAL OF TRACE ELEMENTS IN EXPERIMENTAL MEDICINE, 1997, 10 (01): : 9 - 18
  • [15] New approaches to in vitro models of blood-brain barrier drug transport
    Terasaki, T
    Ohtsuki, S
    Hori, S
    Takanaga, H
    Nakashima, E
    Hosoya, K
    DRUG DISCOVERY TODAY, 2003, 8 (20) : 944 - 954
  • [16] Transport study of interleukin-1 inhibitors using a human in vitro model of the blood-brain barrier
    Sjostrom, Elisabet O.
    Culot, Maxime
    Leickt, Lisa
    Astrand, Mikael
    Nordling, Erik
    Gosselet, Fabien
    Kaiser, Christina
    BRAIN, BEHAVIOR, & IMMUNITY - HEALTH, 2021, 16
  • [17] In Vitro Models of the Blood-Brain Barrier for the Study of Drug Delivery to the Brain
    Wilhelm, Imola
    Krizbai, Istvan A.
    MOLECULAR PHARMACEUTICS, 2014, 11 (07) : 1949 - 1963
  • [18] Mechanisms of glucose transport at the blood-brain barrier: an in vitro study
    McAllister, MS
    Krizanac-Bengez, L
    Macchia, F
    Naftalin, RJ
    Pedley, KC
    Mayberg, MR
    Marroni, M
    Leaman, S
    Stanness, KA
    Janigro, D
    BRAIN RESEARCH, 2001, 904 (01) : 20 - 30
  • [19] In vitro models of the blood-brain barrier to study drug delivery to the brain
    Couraud, Pierre-Olivier
    DRUG METABOLISM REVIEWS, 2009, 41 : 15 - 15
  • [20] Inhibition of P-Glycoprotein: Rapid Assessment of Its Implication in Blood-Brain Barrier Integrity and Drug Transport to the Brain by an In Vitro Model of the Blood-Brain Barrier
    Laurence Fenart
    Valeric Buée-Scherrer
    Laurence Descamps
    Christian Duhem
    Marie-Gwenaëlle Poullain
    Roméo Cecchelli
    Marie-Pierre Dehouck
    Pharmaceutical Research, 1998, 15 : 993 - 1000